Status:

COMPLETED

Reinforcement of Closure of Stoma Site

Lead Sponsor:

University of Birmingham

Collaborating Sponsors:

LifeCell

Conditions:

Hernia

Eligibility:

All Genders

18+ years

Phase:

PHASE2

PHASE3

Brief Summary

ROCSS is a randomised controlled trial of the placement of a biological mesh at the site of stoma closure. Our hypothesis is that reinforcing the stoma closure site with a collagen mesh (Strattice®) i...

Detailed Description

Closure of complex and contaminated abdominal wounds is challenging and carries risks, including wound dehiscence and incisional hernias. Use of biological meshes in these situations may provide a saf...

Eligibility Criteria

Inclusion

  • Require an elective closure of an ileostomy or a colostomy.
  • Able and willing to provide written informed consent.
  • Aged 18 years or over.

Exclusion

  • Taking part in another clinical study which is related to the surgical procedure.
  • Allergic to any porcine or collagen products.
  • History of familial adenomatous polyposis, due to increased risk of desmoid tumours.
  • The surgeon determines that a mesh repair will definitely be required e.g. due to large parastomal hernia.
  • Unable or unwilling to provide written informed consent.

Key Trial Info

Start Date :

November 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 18 2018

Estimated Enrollment :

790 Patients enrolled

Trial Details

Trial ID

NCT02238964

Start Date

November 1 2012

End Date

May 18 2018

Last Update

October 11 2018

Active Locations (35)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 9 (35 locations)

1

Hvidovre Hospital

Copenhagen, Denmark

2

Academisch Medisch Centrum

Amsterdam, Netherlands

3

Tameside General Hospital

Ashton-under-Lyne, United Kingdom

4

Royal United Hospital Bath

Bath, United Kingdom